The {pharmaceutical industry is increasingly exploring alternative treatment strategies for weight management , and the introduction of semaglutide 10mg vials represents a advancement . Clinicians are beginning to assess the potential benefits and risks associated with this higher strength product, especially in relation to existing lower-dose sema